default author photo

Oliver Pötz

SIGNATOPE GmbH

SCHOLARLY PAPERS

2

DOWNLOADS

192

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Antiviral and Immunomodulatory Effect of Zapnometinib in Animal Models and Hospitalized COVID-19 Patients

Number of pages: 59 Posted: 14 Dec 2023
Yvonne Füll, Lara Maria Schüssele, Hazem Hamza, Helen Hoffmann, Martin Bauer, Stephan Stenglein, Oliver Pötz, Andreas Steinhilber, Viktoria Anselm, Mark W. Delany, Judith M.A. van den Brand, Geert van Amerongen, Leon de Waal, Stephan Pleschka, Stephan Ludwig and Oliver Planz Oliver Planz
University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, Atriva Therapeutics GmbH, Atriva Therapeutics GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, SIGNATOPE GmbH, Utrecht University, Utrecht University - Division of Pathology, Cerba Research Company, Cerba Research Company, University of Münster, University of Münster and University of Tübingen
Downloads 160 (467,092)

Abstract:

Loading...

zapnometinib, MEK inhibitor, host targeting agent, COVID-19, drug development, broad-spectrum antiviral

2.

Tyrosine Kinase Inhibitors Induce a Synergistic Response of Hepatocellular Carcinoma Cells to Chemotherapy by Reducing Mrp-Mediated Drug Efflux

Number of pages: 37 Posted: 06 Aug 2025
Ana Peleteiro-Vigil, Anabel Sanchez-Martin, Oscar Briz, Rocio I.R. Macias, Marta Rodríguez, Helen S. Hammer, Oliver Pötz, Maria J. Monte, Jose JG Marin and Elisa Herraez
University of Salamanca, University of Salamanca, University of Salamanca, Carlos III National Institute of Health - Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), University of Salamanca, affiliation not provided to SSRN, SIGNATOPE GmbH, University of Salamanca, University of Salamanca - Experimental Hepatology and Drug Targeting (HEVEPHARM) Group and University of Salamanca
Downloads 32 (1,290,922)

Abstract:

Loading...

ABC transporters, chemoresistance, Liver Cancer, Pharmacology, TKI